Related by context. All words. (Click for frequent words.) 79 Ceplene R 66 Icatibant 66 Amrubicin 65 SEBIVO 65 Ceplene TM 65 Marketing Authorization Application 65 MEPACT 65 ADVEXIN 65 pralatrexate 65 Marqibo 64 PREOS 64 Soliris TM eculizumab 64 Zerenex 64 FOLOTYN 64 Kuvan 64 Dacogen injection 63 Vasovist 63 clofarabine 63 BENLYSTA 63 Loramyc R 63 Increlex R 63 OPAXIO 63 MAA submission 63 Esbriet 63 Privigen 63 satraplatin 63 Marketing Authorization Application MAA 63 refractory Hodgkin lymphoma 63 Rhucin 63 Bronchitol 62 carfilzomib 62 TEMODAL 62 TOCOSOL Paclitaxel 62 Loramyc ® 62 Ranexa 62 Increlex ® 62 ruxolitinib 62 Evoltra 62 ixabepilone 62 Civacir 62 Marketing Authorisation Application 62 Treanda 62 EOquin 62 Plenaxis TM 62 Satraplatin 62 taliglucerase alfa 62 NEBIDO 62 Avastin bevacizumab 62 Nebido 62 valopicitabine 62 Loramyc 62 MOZOBIL 62 Clolar ® 62 Genasense 62 oral ridaforolimus 62 maribavir 61 Vidaza 61 Onrigin 61 fidaxomicin 61 VPRIV 61 OMP designation 61 Evoltra R 61 Virulizin R 61 ganetespib 61 Cimzia 61 PhosLo 61 HuMax CD4 61 perifosine 61 histamine dihydrochloride 61 CoFactor 61 XYOTAX 61 Junovan 61 Allovectin 7 61 Oncophage 61 Evoltra TM 61 tamibarotene 61 Cinryze ™ 61 Noxafil 61 Taxotere ® 61 Amigal 61 lintuzumab 61 PROMACTA 61 SNT MC# 61 Cinryze TM 61 teduglutide 61 Rhucin ® 61 ATryn ® 61 Nexavar ® 61 Dacogen 61 Santhera 61 rilonacept 61 Ruconest 61 Evoltra ® 60 orphan medicinal product 60 orBec 60 L MTP PE 60 Actemra 60 alvimopan 60 orphan designation 60 Mepact 60 Rhucin R 60 ZEVALIN 60 rhThrombin 60 StaphVAX 60 biologic therapy 60 amrubicin 60 Fodosine 60 FIRMAGON R 60 ceftobiprole 60 Cimzia ® 60 pixantrone 60 BENLYSTA ® 60 telbivudine 60 Torisel 60 Mozobil 60 Pixuvri 60 ATryn R 60 sBLA 60 Phase III clinical 60 panitumumab 60 AZILECT ® 60 PXD# 60 Vectibix 60 Dyloject 60 TREDAPTIVE 60 PREOS R 60 Cinryze 60 Actemra tocilizumab 60 MyVax R 60 mifamurtide 60 Esbriet pirfenidone 60 EOquin TM 60 Pirfenidone 60 Cellegesic 60 Plicera 60 Renvela 60 prGCD 60 ularitide 60 NOXAFIL 60 Celgene Revlimid 60 pirfenidone 60 Raptiva ® 60 refractory chronic lymphocytic 60 Revlimid 60 TYZEKA 60 tivozanib 60 sunitinib malate 60 Certican 60 VELCADE 60 Orathecin 60 EFAPROXYN 60 Teysuno 60 #D#C# 60 Fibrillex TM 60 Replagal 60 Phase III trials 60 Cimzia TM 60 OvaRex ® MAb 59 Qutenza 59 Trobalt 59 pivotal Phase III 59 ONGLYZA ™ 59 VEGF Trap 59 Onbrez Breezhaler 59 RG# [001] 59 Preotact 59 Zalbin 59 Onalta 59 Voraxaze 59 Oracea 59 MAXY G# 59 YONDELIS 59 REPLAGAL 59 voreloxin 59 eprotirome 59 Clevudine 59 Gleevec Glivec 59 CHMP recommendation 59 Firazyr 59 COMFORT II 59 Biologics License Application 59 TRISENOX 59 CONBRIZA 59 picoplatin 59 ezogabine 59 AZILECT R 59 relapsed multiple myeloma 59 Plenaxis R 59 SILENOR TM 59 Azixa 59 Xyrem ® 59 Pixantrone 59 ONSOLIS 59 atacicept 59 albinterferon alfa 2b 59 Orphan Drug designation 59 axitinib 59 FACTIVE R gemifloxacin 59 pitavastatin 59 liprotamase 59 Arixtra 59 mipomersen 59 Glybera R 59 IRESSA 59 eltrombopag 59 HuLuc# 59 Increlex TM 59 TREANDA 59 KALBITOR 59 daclizumab 59 SYCREST 59 Extavia 59 intravenous formulation 59 Revlimid lenalidomide 59 ponatinib 59 GTC recombinant human 59 ANTEGREN 59 Aviptadil 59 Folotyn 59 Zenpep 59 Phenoptin 59 Fludara 59 Naglazyme 59 Hexvix 59 Ceftobiprole 59 Lodotra 59 Positive Opinion 59 bifeprunox 59 Bendamustine 59 Telaprevir 59 Cloretazine ® 58 dalbavancin 58 Abraxane 58 Phase 2a trial 58 ranolazine 58 Voraxaze ™ 58 Orphan Drug Designation 58 Yondelis ® 58 Orphan Medicinal Product 58 Marketing Authorization 58 orBec R 58 ELIQUIS 58 Pennsaid R 58 Zebinix R 58 Insegia 58 CAELYX 58 Ceflatonin 58 TYKERB 58 Omigard 58 Mylotarg 58 Ixempra 58 Corlux 58 Restanza 58 Mimpara 58 thymalfasin 58 Ambrisentan 58 subcutaneous formulation 58 Firdapse 58 Riquent 58 Ketotransdel 58 MabCampath 58 indacaterol 58 Removab 58 vosaroxin 58 Campath ® 58 Advagraf 58 FTY# 58 Increlex 58 aztreonam lysine 58 Angiox 58 Combidex 58 Biologics License Application BLA 58 Cloretazine 58 Cladribine 58 sorafenib tablets 58 HQK 58 Bicifadine 58 MGCD# [001] 58 Azilect ® 58 Stedivaze 58 ZENPEP 58 IMA# 58 VIDAZA 58 Dyloject TM 58 Clolar 58 Panzem R NCD 58 Degarelix 58 cinacalcet HCl 58 PLK1 SNALP 58 aflibercept 58 Leukine 58 EpiCept 58 Xyotax 58 Velcade bortezomib 58 Neulasta ® 58 ustekinumab 58 Vandetanib 58 Targretin 58 ridaforolimus 58 Frova ® 58 Trizytek 58 vandetanib 58 Fusilev 58 FOLOTYN ® 58 tafamidis 58 Orphan Drug status 58 palifermin 58 Jevtana 58 RSR# 58 febuxostat 58 Multiferon R 58 Onsolis 58 TORISEL 58 BYDUREON 58 Pemetrexed 58 Centralized Procedure 58 dirucotide 58 tanespimycin 58 bendamustine 58 silodosin 58 amifampridine phosphate 58 TELCYTA 58 Phase 2b trial 58 BLA filing 58 Exforge 58 Vimpat ® lacosamide 58 AeroLEF TM 58 DORIBAX 58 Complete Response 58 Phase III pivotal 58 mapatumumab 58 Nexavar sorafenib 58 teriflunomide 58 Serdolect ® 58 Azedra 58 LymphoStat B 57 Arcalyst 57 Phase IIIb clinical 57 YERVOY 57 bevacizumab Avastin 57 Ventavis 57 bazedoxifene 57 OLEPTRO TM 57 regadenoson 57 Erbitux 57 phase IIb trial 57 Promacta 57 Fx #A 57 SUMAVEL DosePro 57 blinatumomab 57 Advexin 57 Traficet EN 57 enzastaurin 57 registrational 57 Asentar 57 Flutiform TM 57 forodesine 57 LibiGel ® 57 FIRAZYR 57 canakinumab 57 GATTEX TM 57 generation purine nucleoside 57 Alvesco R 57 Allovectin 7 R 57 Aclasta 57 Catena ® 57 Raptiva R 57 MAGE A3 ASCI 57 Inhalation Solution 57 Somatuline R Autogel R 57 Adenuric R 57 Sebivo 57 CHMP opinion 57 Hycamtin 57 IV acetaminophen 57 Zelrix 57 eniluracil 57 Votrient 57 FACTIVE tablets 57 ZEGERID Capsules 57 BCX# 57 Ranolazine 57 tesmilifene 57 omacetaxine 57 azacitidine 57 CYCLOSET 57 Tamibarotene 57 methylnaltrexone 57 Hycamtin ® 57 pegloticase 57 REVLIMID lenalidomide 57 cetuximab Erbitux ® 57 confirmatory Phase III 57 Telzir 57 MYDICAR ® 57 TRISENOX R 57 Ceflatonin R 57 Sycrest 57 mesylate tablets 57 AP# [003] 57 Fortigel 57 Pivotal Phase III 57 ACZ# 57 Androxal ® 57 Telavancin 57 HGS# 57 FavId 57 Medicinal Products EMEA 57 alogliptin 57 Phase 2b study 57 SUTENT 57 Bevacizumab 57 Vidofludimus 57 BEXXAR 57 Xgeva 57 DIFICID 57 glatiramer acetate 57 Strativa 57 INCB# [001] 57 Alzhemed TM 57 EndoTAG TM -1 57 Egrifta 57 Phase 2b clinical 57 Peginterferon alfa 2b 57 Imagify 57 vilazodone 57 Tarceva TM 57 Emselex 57 CIMZIA ™ 57 UPLYSO 57 ATL# [001] 57 ASA# 57 Cimzia ® certolizumab pegol 57 velaglucerase alfa 57 OHR/AVR# 57 Zensana 57 Phase IIb trial 57 INCB# [002] 57 phase IIb clinical 57 phase IIa clinical 57 TYGACIL 57 LEUKINE 57 ONCONASE 57 romiplostim 57 nimotuzumab 57 TYSABRI 57 Cimzia R 57 brivaracetam 57 Erbitux cetuximab 57 eculizumab 57 Synvisc One 57 oxymorphone ER 57 Personalized Immunotherapy 57 Clavis Pharma 57 Tarceva erlotinib 57 AEG# 57 ONTAK 57 rhC1INH 57 Orazol 57 MBP# [001] 57 XGEVA 57 Kepivance 57 ELACYT 57 T Pred 57 Soliris 57 GALNS 57 GATTEX 57 naproxcinod 57 Sorafenib 57 Xanafide 57 Cloretazine R VNP#M 57 Cubicin 57 Phase III Clinical Trial 57 Phase IIa trial 57 Orphan Drug Status 57 octreotide implant 57 Aryplase 57 Orphan Drug designations 57 elacytarabine 57 FOSRENOL 56 ONGLYZA 56 anidulafungin 56 ABRAXANE TM 56 Actimmune ® 56 Bystolic 56 Uplyso 56 ALN RSV# 56 Vilazodone 56 Decentralized Procedure 56 TELINTRA 56 ofatumumab 56 Aptivus 56 CAPHOSOL 56 Firazyr ® 56 Yondelis 56 Everolimus 56 Rasilez 56 BAY #-# 56 Afinitor 56 Rituxan rituximab 56 oritavancin 56 Rescula 56 ambrisentan 56 Orphan Status 56 DPP4 inhibitor 56 REVLIMID 56 ORENCIA R 56 reslizumab 56 SinuNase 56 Retacrit 56 AQ4N 56 RhuDex ® 56 APTIVUS 56 obatoclax 56 Orphan Drug 56 PROVENGE ® 56 Evicel 56 PrevOnco 56 INT# [002] 56 NPSP# 56 Soliris eculizumab 56 Brilique 56 Pennsaid 56 Seroquel XR 56 MuGard 56 levocetirizine 56 QVAR 56 StaphVAX R 56 Rasilez Tekturna 56 G CSF 56 Myocet 56 Desmoteplase 56 tesamorelin 56 phase IIb 56 iloperidone 56 SIR Spheres 56 Pralatrexate 56 pivotal Phase 56 Zevalin 56 Ilaris 56 adalimumab 56 Cleviprex TM clevidipine 56 Genasense ® 56 Allovectin 7 ® 56 Stelara 56 Troxatyl 56 JOULFERON 56 investigational drug 56 ofatumumab HuMax CD# 56 ABRAXANE 56 Onrigin TM 56 Adcirca 56 BREAKYL 56 ipilimumab 56 peginesatide 56 sapacitabine 56 mTOR inhibitor 56 glufosfamide 56 EpiCept NP 1 56 Flutiform 56 dacetuzumab 56 PEG PAL 56 Xcytrin 56 Anturol 56 vemurafenib 56 Uvidem 56 Galvus 56 Proxinium TM 56 HepaSphere 56 registrational trial 56 Rasagiline 56 FUSILEV 56 talactoferrin 56 TheraCIM 56 relapsed refractory multiple myeloma 56 sorafenib Nexavar 56 Rebif ® 56 BrachySil TM 56 Cetrorelix 56 mRCC 56 trabectedin 56 Aloxi R 56 Application BLA 56 Onco TCS 56 PEG INTRON 56 IMiDs 56 APF# 56 Vectibix panitumumab 56 PDX pralatrexate 56 MabThera 56 Reolysin 56 Golimumab 56 Sandostatin LAR 56 NUVIGIL 56 Aptivus ® 56 Glufosfamide 56 ATPace TM 56 XmAb# 56 Relistor 56 Rituxan 56 Romiplostim 56 telaprevir 56 Pazopanib 56 brentuximab vedotin 56 Fosrenol 56 REVLIMID R 56 palifosfamide 56 denufosol 56 HoFH 56 post menopausal osteoporosis 56 Ranexa R 56 refractory metastatic colorectal cancer 56 liposomal formulation 56 BLA submission 56 APPRAISE 56 mesylate 56 CYT# 56 Multaq R 56 Febuxostat 56 REBETOL combination therapy 56 Canvaxin 56 Tyvaso 56 BARACLUDE R 56 Zavesca r 56 Ciclesonide 56 PDE4 inhibitor 56 Panzem R 56 Augment Bone Graft 56 efalizumab 56 VALSTAR 56 OFIRMEV 56 Taxotere R 56 Macroplastique 56 oral anticoagulant 56 Lenalidomide 56 ALVESCO R 56 acyclovir Lauriad ® 56 AGGRASTAT ® 56 Vibativ 56 Orphan Designation 56 Archexin 56 temsirolimus 56 myelodysplastic syndromes MDS 56 Mipomersen 56 DAVANAT 56 Nuedexta 56 Certriad 56 ZOLINZA 56 tocilizumab 56 Bazedoxifene 56 Marketing Authorisation Application MAA 56 radiation sensitizer 56 oral prodrug 56 Viramidine 56 Phase IIb clinical 56 Tostrex 56 elotuzumab 56 Bifeprunox 56 Zingo TM 56 BEMA TM Fentanyl 56 TRISENOX ® 56 Bonefos 56 oral methylnaltrexone 56 Oncoscience AG 56 ABRAXANE ® 56 Silodosin 56 KRN# 56 Betaferon ® 56 Phase IIa 56 Orapred ODT 56 tecarfarin 55 Phase Ib 55 ZEVALIN ® 55 R sorafenib tablets 55 Octreolin 55 Preotact R 55 BrachySil 55 NDA submission 55 Kynapid 55 Phase 1b trial 55 Keppra ® levetiracetam 55 pexelizumab 55 RoACTEMRA 55 topical NSAID 55 JAK inhibitor 55 Clofarabine 55 zalutumumab 55 sNDA 55 Zenvia 55 IND submission 55 SANVAR 55 Marketing Authorisation 55 Gabapentin GR 55 AzaSite Plus 55 nebivolol 55 Mycamine 55 ELADUR 55 DR Cysteamine 55 INC# 55 Tavocept 55 rALLy trial 55 voclosporin 55 torezolid phosphate 55 CD# antibody [001] 55 DYNEPO 55 Perifosine 55 Dificid 55 aclidinium bromide 55 Aphthasol R 55 celgosivir 55 terlipressin 55 Krystexxa 55 Alvesco 55 HuMax EGFr 55 riociguat 55 almorexant 55 Exalgo 55 pradefovir 55 Rasilamlo 55 Targretin capsules 55 clinical trial 55 MYDICAR 55 Dalbavancin 55 clinical trials 55 Pfizer Sutent 55 Fibrin Pad 55 IMGN# 55 Neuromodulation System 55 ISTODAX 55 ProLindac 55 Trastuzumab 55 Glybera 55 Campath 55 Exelbine 55 vinorelbine 55 eprodisate KIACTA TM 55 Daliresp 55 Erlotinib 55 RELISTOR 55 COPAXONE ® 55 TMC# [001] 55 Phase III clinical trials 55 ARIXTRA 55 severe hypercholesterolemia 55 Cimzia certolizumab pegol 55 forodesine HCl 55 PROVENGE 55 RAPAFLO 55 proprietary transdermal patch 55 LymphoStat B belimumab 55 RDEA# 55 Nabi HB Intravenous 55 ceftaroline 55 cangrelor 55 zileuton CR 55 Azedra TM 55 supplemental Biologics License Application 55 Dasatinib 55 Application MAA 55 Phase IIa clinical 55 Kamada AAT 55 PegIntron 55 HuMax CD# 55 Phase III Trial 55 Tygacil 55 Angiox ® 55 SUTENT ® 55 Stimuvax R 55 Movectro 55 PHX# 55 neratinib 55 Filgrastim 55 VNP#M 55 Adenuric ® 55 ATACAND 55 STELARA TM 55 LAF# 55 humanized anti 55 TRO# 55 Hematide 55 Vascular Wrap TM 55 faropenem 55 rNAPc2 55 Virulizin ® 55 Ferumoxytol 55 indiplon 55 AERx iDMS 55 Betaferon R 55 SILENOR 55 Xinlay 55 decitabine 55 Tezampanel 55 TKM ApoB 55 Betaferon 55 YONDELIS R 55 Orphan designation 55 Trexima 55 Thalidomide Pharmion 55 Panzem 55 QAB# 55 pain palliation 55 cell lymphoma CTCL 55 HGS ETR1 55 lymphoma CTCL 55 CDP# 55 lapatinib Tykerb 55 vidofludimus 55 ISENTRESS 55 IPLEX 55 Tracleer r 55 systemic immunosuppressive drugs 55 Rituximab 55 Pertuzumab 55 ProSavin 55 Androxal 55 Caelyx 55 XL# [003] 55 MyVax 55 Thalomid 55 Rivaroxaban 55 Iluvien ® 55 alvespimycin 55 Prestara 55 Saforis 55 Genentech Roche 55 relapsed SCLC 55 Carfilzomib 55 PRT# 55 PMA submission 55 BAL# [002] 55 THALOMID 55 ISIS # 55 Joulferon 55 SEROQUEL XR 55 XIAFLEX ™ 55 relapsing multiple sclerosis 55 Abstral 55 Sular formulation 55 oropharyngeal candidiasis 55 Tekturna HCT 55 Luveniq 55 Besivance 55 EGRIFTA TM 55 confirmatory Phase 3 55 ZALBIN 55 Toctino R 55 Bydureon 55 otelixizumab 55 sunitinib 55 ERBITUX 55 PNP inhibitor 55 fenofibrate 55 PS# [001] 55 Nexavar 55 CINOD 55 HUMIRA 55 Feraheme 55 vildagliptin 55 FRDA 55 phase IIa 55 Tekamlo 55 oncology indications 55 Perforomist ™ Inhalation Solution 55 Bortezomib 55 OncoVEX GM CSF 55 apaziquone 55 anticancer agent 55 antiplatelet agent 55 Preos 55 Azilect R 55 Interferon beta 1a 55 Indaflex TM 55 New Drug Application 55 Cladribine Tablets 55 Anturol TM 55 ospemifene 55 QNEXA 55 ZYBRESTAT 55 IV APAP 55 LEVADEX ™ 55 desvenlafaxine 55 Gemzar ® 55 Adalimumab 55 refractory multiple myeloma 55 Xolegel 55 AVASTIN 55 balsalazide tablet 55 AVN# [001] 55 Xenazine ® 55 XIAPEX 54 investigational compound 54 incyclinide 54 Rasilez HCT 54 posaconazole 54 Phase IIIb study 54 Menerba 54 Simulect 54 refractory systemic ALCL 54 pertuzumab 54 Specifid 54 WILEX 54 Phase III 54 Topotecan 54 iclaprim 54 chronic angina 54 Annamycin 54 NEUPOGEN 54 Alemtuzumab 54 pomalidomide 54 pegfilgrastim 54 Herceptin trastuzumab 54 Qutenza TM 54 Receives Marketing Authorization 54 Feraheme ® 54 Neuradiab 54 Levoleucovorin 54 hereditary deficiency 54 THELIN 54 Sanctura XR 54 PROVIGIL 54 NEUMUNE 54 Camvia 54 Solazed 54 Oracea ® 54 Phase IIb trials 54 IIa trial 54 Homspera 54 Velcade 54 pediatric acute lymphoblastic 54 Emezine 54 vorinostat 54 Vivaglobin 54 SomatoKine 54 sipuleucel T 54 Actimmune R 54 Nimotuzumab 54 Keppra ® 54 Junovan TM 54 Tanespimycin 54 ZADAXIN 54 randomized Phase IIb 54 Leukine ® 54 investigational antiplatelet agent 54 Natalizumab 54 cutaneous T cell 54 SUMAVEL 54 Æterna Zentaris 54 XIAFLEX 54 PEGINTRON TM 54 Neupro ® 54 ACOMPLIA R 54 Laquinimod 54 OMAPRO 54 NP2 Enkephalin 54 Study GL# 54 Zolinza 54 Urocidin 54 ASONEP 54 CIMZIA TM 54 Amgen Vectibix 54 CHMP 54 PEG Interferon lambda 54 HspE7 54 pharmacokinetic studies 54 vernakalant 54 STELARA 54 B CLL 54 CytoFab 54 clevudine 54 ImClone Erbitux 54 Denosumab 54 Nplate 54 ecallantide 54 linaclotide 54 FDA Complete Response 54 Tarceva 54 Tocosol Paclitaxel 54 PROVENGE sipuleucel T 54 TPI ASM8 54 TH# [003] 54 Dabigatran etexilate 54 ThermoDox ® 54 AEGR 54 metastatic renal cell carcinoma 54 AMR# 54 Itopride 54 Xarelto 54 T DM1 54 VIAject 54 orphan drug 54 Aplidin 54 tezampanel 54 vinflunine 54 surrogate endpoint 54 BiovaxID 54 OMNARIS HFA 54 Intermezzo R 54 GATTEX ® 54 LHRH antagonist